产品分类
Product Category
CO1686 1374640-70-6 CO-1686 is a novel, irreversible and orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M(IC50=21 nM).
Dabrafenib Mesylate 1195768-06-9 Dabrafenib is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity.
XL-888 1149705-71-4 XL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
CI-994 112522-64-2 CI994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.57 μM.
Carfilzomib (PR-171) 868540-17-4 Carfilzomib (PR-171) is a proteasome inhibitor with IC50 less than 5 nM.
ONX-0912(Oprozomib) 935888-69-0 Oprozomib (ONX 0912) selectively inhibits CT-L activity of 20S proteasome β5/LMP7 with IC50 of 36 nM/82 nM.
LY-364947 396129-53-6 LY-364947 is a potent ATP-competitive inhibitor of TGFβR-I with IC50 of 59 nM, shows 7-fold selectivity over TGFβR-II.
ICG-001 780757-88-2;847591-62-2 ICG-001 is a small-molecule antagonist of b-catenin/TCF-mediated transcription (IC50 = 3 uM) and specifically downregulates the expression of a subset of b-catenin/TCF
电话
微信扫一扫